EP2609120A4
(en )
2013-10-02
Improved process for preparation of sugammadex
HK1201042A1
(en )
2015-08-21
Compositions for the treatment of dry eye
PL2773331T3
(en )
2016-08-31
Formulations for the treatment of diabetes
EP2552874A4
(en )
2015-11-04
Process for the manufacture of hexafluoro-2-butene
IL220523A0
(en )
2012-08-30
New process for the preparation of dronedarone
EP2558432A4
(en )
2013-10-09
Process for the manufacture of tetrafluoroolefins
PL2632889T3
(en )
2019-04-30
Intermediate compounds and process for the preparation of fingolimod
SG2014014724A
(en )
2014-07-30
METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
SG11201400939YA
(en )
2014-07-30
Process for the preparation of methoxymelonal
EP2640711A4
(en )
2014-02-12
Improved process for the preparation of rufinamide
ZA201207397B
(en )
2013-06-26
Process for the preparation of dexlansoprazole
HUP1000565A2
(en )
2012-05-02
Process for the preparation of pharmaceutically active compound and intermediers
EP2596007A4
(en )
2014-07-30
Process for the preparation of 17-desoxy-corticosteroids
ZA201300546B
(en )
2018-12-19
Process for the preparation of 3-haloalkylpyrazoles
PT2603319E
(en )
2014-12-19
Process for the preparation of urethans
PL2593423T3
(en )
2015-03-31
Process for the preparation of contrast agents
EP2571836A4
(en )
2014-08-27
Process for the preparation of hexafluoro-2-butyne
PT2390246T
(en )
2018-11-30
Process for the preparation of aminaphtone
PL391137A1
(en )
2011-11-07
Process for the preparation of active carbonic nanofibres
PL2598504T3
(en )
2014-10-31
Process for the preparation of dimiracetam
IL224304A
(en )
2015-06-30
Process for the preparation of dichlorofulvene
PL391702A1
(en )
2012-01-02
Process for the preparation of 5-hydroxycreatinine and N-methylguanidine
GB201019641D0
(en )
2010-12-29
The process of delivering o-vouchers
IL226042A0
(en )
2013-06-27
Intermediate compounds and process for the preparation of fingolimod
HK1196953A1
(en )
2014-12-24
Formulations for the treatment of diabetes